Clinical Potential of a Silk Sericin-Releasing Bioactive Wound Dressing for the Treatment of Split-Thickness Skin Graft Donor Sites
- 877 Downloads
An ethyl alcohol-precipitated silk sericin/PVA scaffold that controlled the release of silk sericin was previously developed and applied for the treatment of full-thickness wounds in rats and demonstrated efficient healing. In this study, we aimed to further evaluate the clinical potential of this scaffold, hereafter called “silk sericin-releasing wound dressing”, for the treatment of split-thickness skin graft donor sites by comparison with the clinically available wound dressing known as “Bactigras®”.
In vitro characterization and in vivo evaluation for safety of the wound dressings were performed. A clinical trial of the wound dressings was conducted according to standard protocols.
The sericin released from the wound dressing was not toxic to HaCat human keratinocytes. A peel test indicated that the silk sericin-releasing wound dressing was less adhesive than Bactigras®, potentially reducing trauma and the risk of repeated injury upon removal. There was no evidence of skin irritation upon treatment with either wound dressing. When tested in patients with split-thickness skin graft donor sites, the wounds treated with the silk sericin-releasing wound dressing exhibited complete healing at 12 ± 5.0 days, whereas those treated with Bactigras® were completely healed at 14 ± 5.2 days (p = 1.99 × 10−4). In addition, treatment with the silk sericin-releasing wound dressing significantly reduced pain compared with Bactigras® particularly during the first 4 postoperative days (p = 2.70 × 10−5 on day 1).
We introduce this novel silk sericin-releasing wound dressing as an alternative treatment for split-thickness skin graft donor sites.
KEY WORDSclinical trial silk sericin split-thickness skin graft wound dressing wound healing
ACKNOWLEDGMENTS AND DISCLOSURES
We gratefully acknowledge the financial support from the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0115/2551) to Tippawan Siritientong and Pornanong Aramwit and also the support from the National Research Council of Thailand.
- 8.van der Weyden EA. Treatment of a venous leg ulcer with a honey alginate dressing. Br J Community Nurs. 2005;10:S21, S24, S26-S27.Google Scholar
- 22.Standard Methods for the Examination of Water and Wastewater, Copyright by American Public Health Association, American Water Works Association, Water Environment Federation, 1999. Available from URL: http://www.mwa.co.th/download/file_upload/SMWW_1000-3000.pdf.
- 25.ISO10993-6. Biological evaluation of medical devices—part 6: tests for local effects after implantation.Google Scholar
- 30.Angspatt A, Taweerattanasil B, Janvikul W, Chokrungvaranont P, Wimon S. Carboxymethylchitosan, alginate and tulle gauze wound dressings: a comparative study in the treatment of partial-thickness wounds. Asian Biomed. 2011;5:413–6.Google Scholar